$AEHR

SALAMONE ALBERTO sold $1.2M of AEHR

SALAMONE ALBERTO (EVP, PPBI BUSINESS) sold 9,672 shares of AEHR TEST SYSTEMS (AEHR) at an average of $127.72 ($127.50–$128.00, $1.24M total) across 2 trades on 2026-08-13.

Original reporting
SEC EDGAR · SALAMONE ALBERTO
Published Aug 14, 2026, 6:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 6:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not change AEHR fundamentals based on the provided text.

02

Market read

Traders may monitor whether this sale is part of broader insider selling, but there is no new guidance, contract, or regulatory development in the text.

03

What to watch

The absence of a disclosed 10b5-1 plan can raise scrutiny, but the article does not provide context on prior grants, option exercises, or total insider selling cadence.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-14 after-hours; transaction dated 2026-08-13

Background

This is an SEC Form 4 insider transaction disclosure for AEHR, reported by EVP Alberto Salamone.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR insider Form 4 shows EVP Alberto Salamone sold 9,672 shares in open-market trades for about $1.24M on 2026-08-13.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and limited unless follow-on selling accelerates.

Evidence & confidence

The filing is a primary-source Form 4, but it provides no new company-specific operational or financial information, and insider sales are often non-informational.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • AEHR

    AEHR Test Systems, the company whose insider transaction is disclosed.

  • Alberto Salamone

    EVP, PPBI Business, who sold 9,672 shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHighAI 8/10

AEHR Stock Rips On AI Orders And Bullish Jefferies Call

Aehr Test Systems (NASDAQ: AEHR) rose about 7% after upbeat earnings and strong semiconductor test demand. The article cites a $22M AI follow-on production order and a Jefferies Buy call with a $175 price target. It also notes quarterly revenue of about $18.84M, gross margin 35.3%, and $116.36M cash.

$AEHRMed

Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.

Jefferies initiated coverage of Aehr Test Systems (AEHR) with a Buy rating and $175 price target, citing a conservative model based on existing production and backlog. The stock rose about 8% midday and is up over 510% YTD, after AI-driven semiconductor testing demand. Peers TER, COHU, FORM, and ONTO also gained; AEHR faces valuation and revenue volatility risks.

$AEHRHighAI 9/10

Why is Aehr Test Systems stock surging today?

Investing.com reports Aehr Test Systems (AEHR) shares rose 10.7% after the company said it received a $22 million follow-on production order from a lead wafer-level AI processor customer. The order covers FOX-XP burn-in systems, FOX WaferPak contactors, and Auto Aligners. AEHR also reported fiscal Q4 2026 profit of $0.11 EPS on ~$18.8M revenue and guided fiscal 2027 revenue to $130–$150M.

$AEHRMedAI 8/10

A $22 Million Reason Why AEHR Stock Is Up Today

Aehr Test Systems (AEHR) shares rose Aug. 12 after the company said it received a $22 million follow-on production order from its lead AI processor customer for automated wafer-level test systems. The order covers FOX-XP WLBI systems and related components, shipping over six months for installation in Taiwan. Investors cited demand tied to AI chip manufacturing; AEHR trades around 212x forward earnings and has a mean $115 price target.